Vision loss is something most people associate with accidents. A sharp object. A chemical splash. A sudden injury. Very few ...
The M5 refresh makes the new Apple Vision Pro faster and improves some features, but it doesn't change the fact that the ...
Winter dryness, indoor heating and screen time can disrupt the tear film, leading to dry, irritated eyes. Doctors explain ...
Primary care physicians are often the first to notice transient ischemic attack stroke symptoms or risks. The right questions can help determine next steps.
Blurred vision is often dismissed as tired eyes or screen fatigue, but an eye specialist warns that it can be an early ...
It’s easy to dismiss brief vision changes as just “one of those things” in the body, especially if they don’t hurt or seem to go away quickly. But eye specialists say some of these seemingly small ...
The actress, 90, first revealed in 2012 that she was diagnosed with age-related macular degeneration Erin Clack is a Staff Editor for PEOPLE. She has been writing about fashion, parenting and pop ...
The actress was previously diagnosed with macular degeneration. By Carly Thomas Associate Editor The Oscar winner previously shared that she was diagnosed with age-related macular degeneration.
TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...
There is a new FDA-approved eye drop on the market called Vizz. This once-daily, prescription eye drop is said to help combat presbyopia, otherwise known as age-related blurry vision. Drugmaker LENZ ...
For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...
Senior Lecturer, Adult Nursing and co-lead, Ageing, Acute and Long Term Conditions. Member of Health and Well Being Research Center, London South Bank University Stroke can happen to anyone, at any ...